P. Michael Ho, MD, PhD1-3
Articles
Medication nonadherence and adverse outcomes in CAD patients
P. Michael Ho, MD, PhD1-3;David J. Magid, MD, MPH2,3;Susan M. Shetterly, MS3;Kari L. Olson, PharmD, BCPS2,4;Thomas M. Maddox, MD, SM1-3;Pamela N. Peterson, MD, MSPH2,3,5;Frederick A. Masoudi, MD
February 18th 2009Nonadherence to beta blockers, statins, or angiotensin-converting enzyme inhibitors is common (21%-29%) among patients with coronary artery disease (CAD). Patients who do not adhere to their medication regimens are at increased risk of mortality, cardiovascular hospitalizations, and revascularization procedures; thus, medication nonadherence should be a target for quality improvement interventions to maximize the outcomes of CAD patients.
Read More
Latest Updated Articles
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: November 19th 2024 | Updated: November 22nd 2024
Laura Hamant, MD: Standardized Algorithm Increases VTE Prophylaxis Among Children
Published: October 9th 2014 | Updated: November 22nd 2024
Widespread "Yellow Bumps"
Published: November 18th 2024 | Updated: November 22nd 2024
The Medical Sisterhood: Role Models and Mentorship, with Susan Taylor, MD, and Linda Stein Gold, MD
Published: November 16th 2024 | Updated: November 22nd 2024
John Stone, MD, MPH: Inebilizumab Efficacious for IgG4-Related Disease in MITIGATE Study
